DAWNA HILTON: Open Payments
NPI 1932443694 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,020 in 45 payments from 21 companies in 2025. Trend: 2023 $1,133 · 2024 $1,415 · 2025 $2,020
Food & beverage: $2,020
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $336 |
| Kestra Medical Technology Services, Inc. | 10 | $277 |
| Amgen Inc. | 5 | $148 |
| Medtronic, Inc. | 1 | $146 |
| ABIOMED | 1 | $133 |
| CVRx, Inc. | 3 | $123 |
| Actelion Pharmaceuticals US, Inc. | 1 | $122 |
| Xeris Pharmaceuticals, Inc. | 1 | $122 |
| GlaxoSmithKline, LLC. | 1 | $118 |
| Eisai Inc. | 1 | $103 |
Products named: Assure WCD, Ozempic, REPATHA, SYMPLICITY G3, Barostim Neo System, GVOKE HYPOPEN, UPTRAVI, AREXVY.
Industry payments across FL — which companies pay providers there.
